pubmed-article:18714982 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:18714982 | lifeskim:mentions | umls-concept:C0026339 | lld:lifeskim |
pubmed-article:18714982 | lifeskim:mentions | umls-concept:C0026336 | lld:lifeskim |
pubmed-article:18714982 | lifeskim:mentions | umls-concept:C0442027 | lld:lifeskim |
pubmed-article:18714982 | lifeskim:mentions | umls-concept:C0031727 | lld:lifeskim |
pubmed-article:18714982 | lifeskim:mentions | umls-concept:C0441655 | lld:lifeskim |
pubmed-article:18714982 | lifeskim:mentions | umls-concept:C1417016 | lld:lifeskim |
pubmed-article:18714982 | lifeskim:mentions | umls-concept:C0010424 | lld:lifeskim |
pubmed-article:18714982 | lifeskim:mentions | umls-concept:C2698650 | lld:lifeskim |
pubmed-article:18714982 | lifeskim:mentions | umls-concept:C1515655 | lld:lifeskim |
pubmed-article:18714982 | pubmed:issue | 18 | lld:pubmed |
pubmed-article:18714982 | pubmed:dateCreated | 2008-9-19 | lld:pubmed |
pubmed-article:18714982 | pubmed:abstractText | The optimization of the dihydronaphthyl[3,4-a]pyrrolo[3,4-c]carbazole-5-one R(2) and R(12) positions led to the identification of the first MLK1 and MLK3 subtype-selective inhibitors within the MLK family. Compounds 14 (CEP-5104) and 16 (CEP-6331) displayed good potency for MLK1 and MLK3 inhibition with a greater than 30- to 100-fold selectivity for related family members MLK2 and DLK. Compounds 14 and 16 were orally active in vivo in a mouse MPTP biochemical efficacy model that was comparable to the first-generation pan-MLK inhibitor 1 (CEP-1347). The MLK1 structure-activity relationships were supported by the first-reported X-ray crystal structure of MLK1 bound with 16. | lld:pubmed |
pubmed-article:18714982 | pubmed:language | eng | lld:pubmed |
pubmed-article:18714982 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18714982 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:18714982 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18714982 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18714982 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18714982 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18714982 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18714982 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18714982 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:18714982 | pubmed:month | Sep | lld:pubmed |
pubmed-article:18714982 | pubmed:issn | 1520-4804 | lld:pubmed |
pubmed-article:18714982 | pubmed:author | pubmed-author:MurkJ LJL | lld:pubmed |
pubmed-article:18714982 | pubmed:author | pubmed-author:AlmoSteven... | lld:pubmed |
pubmed-article:18714982 | pubmed:author | pubmed-author:AngelesThelma... | lld:pubmed |
pubmed-article:18714982 | pubmed:author | pubmed-author:AtorMark AMA | lld:pubmed |
pubmed-article:18714982 | pubmed:author | pubmed-author:MathiasenJoan... | lld:pubmed |
pubmed-article:18714982 | pubmed:author | pubmed-author:SaporitoMicha... | lld:pubmed |
pubmed-article:18714982 | pubmed:author | pubmed-author:Bozyczko-Coyn... | lld:pubmed |
pubmed-article:18714982 | pubmed:author | pubmed-author:HudkinsRobert... | lld:pubmed |
pubmed-article:18714982 | pubmed:author | pubmed-author:ScottRichard... | lld:pubmed |
pubmed-article:18714982 | pubmed:author | pubmed-author:MallamoJohn... | lld:pubmed |
pubmed-article:18714982 | pubmed:author | pubmed-author:FedorovAlexan... | lld:pubmed |
pubmed-article:18714982 | pubmed:author | pubmed-author:AimoneLisa... | lld:pubmed |
pubmed-article:18714982 | pubmed:author | pubmed-author:MeyerSheryl... | lld:pubmed |
pubmed-article:18714982 | pubmed:author | pubmed-author:HolskinBeverl... | lld:pubmed |
pubmed-article:18714982 | pubmed:author | pubmed-author:DurkinJohn... | lld:pubmed |
pubmed-article:18714982 | pubmed:author | pubmed-author:ParkChung... | lld:pubmed |
pubmed-article:18714982 | pubmed:author | pubmed-author:HustenJeanJ | lld:pubmed |
pubmed-article:18714982 | pubmed:author | pubmed-author:FedorovElena... | lld:pubmed |
pubmed-article:18714982 | pubmed:author | pubmed-author:DieboldJames... | lld:pubmed |
pubmed-article:18714982 | pubmed:author | pubmed-author:JosefKurt AKA | lld:pubmed |
pubmed-article:18714982 | pubmed:issnType | Electronic | lld:pubmed |
pubmed-article:18714982 | pubmed:day | 25 | lld:pubmed |
pubmed-article:18714982 | pubmed:volume | 51 | lld:pubmed |
pubmed-article:18714982 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:18714982 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:18714982 | pubmed:pagination | 5680-9 | lld:pubmed |
pubmed-article:18714982 | pubmed:dateRevised | 2011-11-2 | lld:pubmed |
pubmed-article:18714982 | pubmed:meshHeading | pubmed-meshheading:18714982... | lld:pubmed |
pubmed-article:18714982 | pubmed:meshHeading | pubmed-meshheading:18714982... | lld:pubmed |
pubmed-article:18714982 | pubmed:meshHeading | pubmed-meshheading:18714982... | lld:pubmed |
pubmed-article:18714982 | pubmed:meshHeading | pubmed-meshheading:18714982... | lld:pubmed |
pubmed-article:18714982 | pubmed:meshHeading | pubmed-meshheading:18714982... | lld:pubmed |
pubmed-article:18714982 | pubmed:meshHeading | pubmed-meshheading:18714982... | lld:pubmed |
pubmed-article:18714982 | pubmed:meshHeading | pubmed-meshheading:18714982... | lld:pubmed |
pubmed-article:18714982 | pubmed:meshHeading | pubmed-meshheading:18714982... | lld:pubmed |
pubmed-article:18714982 | pubmed:meshHeading | pubmed-meshheading:18714982... | lld:pubmed |
pubmed-article:18714982 | pubmed:meshHeading | pubmed-meshheading:18714982... | lld:pubmed |
pubmed-article:18714982 | pubmed:meshHeading | pubmed-meshheading:18714982... | lld:pubmed |
pubmed-article:18714982 | pubmed:meshHeading | pubmed-meshheading:18714982... | lld:pubmed |
pubmed-article:18714982 | pubmed:meshHeading | pubmed-meshheading:18714982... | lld:pubmed |
pubmed-article:18714982 | pubmed:meshHeading | pubmed-meshheading:18714982... | lld:pubmed |
pubmed-article:18714982 | pubmed:year | 2008 | lld:pubmed |
pubmed-article:18714982 | pubmed:articleTitle | Mixed-lineage kinase 1 and mixed-lineage kinase 3 subtype-selective dihydronaphthyl[3,4-a]pyrrolo[3,4-c]carbazole-5-ones: optimization, mixed-lineage kinase 1 crystallography, and oral in vivo activity in 1-methyl-4-phenyltetrahydropyridine models. | lld:pubmed |
pubmed-article:18714982 | pubmed:affiliation | Discovery Research, Cephalon, Incorporated, 145 Brandywine Parkway, West Chester, Pennsylvania 19380, USA. rhudkins@cephalon.com | lld:pubmed |
pubmed-article:18714982 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:18714982 | pubmed:publicationType | In Vitro | lld:pubmed |
http://linkedlifedata.com/r... | http://linkedlifedata.com/r... | pubmed-article:18714982 | lld:chembl |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18714982 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18714982 | lld:pubmed |